Latest filing published 30 Oct 2026 for ARS Pharmaceuticals, Inc., €241k.
Insider track record
Eric Karas: trading record in brief
This profile gathers the share dealings of Eric Karas in ARS Pharmaceuticals, Inc. We count 6 filings; the first trade dates from 12 June 2026 and the latest from 30 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 30 October 2026 with a transaction (€241k) in ARS Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eric Karas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 80,000 shares@ US$3.3784CommonSEC144:0001950047-26-010513
- 100,000 shares@ US$4.10240.10% mcap26.1% of flowCommonSEC144:0001950047-26-010301
- 100,000 shares@ US$4.2610.097% mcap36.4% of flowCommonSEC144:0001950047-26-009969
- 100,000 shares@ US$4.31560.099% mcap58.0% of flowCommonSEC144:0001950047-26-009892
- 14,064 shares@ US$4.96030.017% mcap4.3% of flowCommonSEC144:0001950047-26-009329
- 25,000 shares@ US$10.000.031% mcap78.2% of flowCommonSEC144:0001950047-26-006004
6 of 6 declarations
